Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 1048-1052, December 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbut, P. A.
Right arrow Articles by Kraemer, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbut, P. A.
Right arrow Articles by Kraemer, W. H.

The Possible Role of the Properdin System in Transplantable Cancer

The Effect of Zymosan on Transplantable Human Carcinoma

Peter A. Herbut and William H. Kraemer

( Elizabeth Storck Kraemer Memorial Foundation and Department of Pathology, Jefferson Medical College and Hospital, Philadelphia, Pennsylvania)

The possible role of the properdin system in the growth of heterologously transplanted tumors was investigated by observing the effects of zymosan on the transplantable human carcinoma of the colon HR132 in normally resistant weanling Wistar rats.

Out of a total of 160 animals in each category, the number of tumor "takes" was as follows: nineteen in nontreated animals, 136 in irradiated animals, 58 in animals given a single injection of zymosan, and 90 in animals given multiple injections of zymosan.

From the data presented, it seems reasonable to conclude that zymosan is effective in increasing the susceptibility of weanling Wistar rats to HR132. Whether this conditioning is mediated through the properdin system or through some other mechanism remains to be determined.

Received 7/13/56.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.